APHERESIS RELATED COMPLICATION

APHERESIS RELATED COMPLICATION was reported 15 times

APHERESIS RELATED COMPLICATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Autologous Cellular Immunotherapy [EPC] 2 0.0003
1 CD19-directed Chimeric Antigen Receptor [EPC] 3 0.0003
2 P2Y12 Platelet Inhibitor [EPC] 5 0.0000
3 Angiotensin Converting Enzyme Inhibitor [EPC] 5 0.0000
4 Aldosterone Antagonist [EPC] 5 0.0000
5 Complement Inhibitor [EPC] 1 0.0000
6 Loop Diuretic [EPC] 5 0.0000
7 Interferon beta [EPC] 1 0.0000